EGL-001

· Egle Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EGL-001, covering 2024-11-07 to 2024-11-07. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors [Phase 1, Phase 2]

See pricing